Equities

Smith & Nephew PLC

SN.:LSE

Smith & Nephew PLC

Health CareMedical Equipment and Services
  • Price (GBX)1,267.00
  • Today's Change-26.50 / -2.05%
  • Shares traded2.15m
  • 1 Year change23.61%
  • Beta1.0587
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
OPERATIONS
Net income498290235
Depreciation/depletion645683617
Non-Cash items209188264
Cash taxes paid, supplemental14012547
Cash interest paid, supplemental14010473
Changes in working capital(365)(553)(648)
Total cash from operations987608468
INVESTING
Capital expenditures(381)(427)(358)
Other investing and cash flow items, total(188)(21)(114)
Total cash from investing(569)(448)(472)
FINANCING
Financing cash flow items04.003.00
Total cash dividends paid(327)(327)(327)
Issuance (retirement) of stock, net1.000(152)
Issuance (retirement) of debt, net240123(450)
Total cash from financing(86)(200)(926)
NET CHANGE IN CASH
Foreign exchange effects(15)(4)(11)
Net change in cash317(44)(941)
Net cash-begin balance/reserved for future use3003441,285
Net cash-end balance/reserved for future use617300344
SUPPLEMENTAL INCOME
Depreciation, supplemental645683617
Cash interest paid, supplemental14010473
Cash taxes paid, supplemental14012547
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.